Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA
RNA interference (RNAi) may provide a therapeutic solution to many pulmonary epithelium diseases. However, the main barrier to the clinical use of RNAi remains the lack of efficient delivery vectors. Research has mainly concentrated on the intranasal route of delivery of short interfering RNA (siRNA...
Main Authors: | Jana McCaskill, Richa Singhania, Melinda Burgess, Rachel Allavena, Sherry Wu, Antje Blumenthal, Nigel AJ McMillan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2013-01-01
|
Series: | Molecular Therapy: Nucleic Acids |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S216225311630155X |
Similar Items
-
Liposomes: structure, composition, types, and clinical applications
by: Hamdi Nsairat, et al.
Published: (2022-05-01) -
Anionic liposomes prepared without organic solvents for effective siRNA delivery
by: Xiu Han, et al.
Published: (2023-05-01) -
In Vitro Inhibition of Replication of Dengue Virus Serotypes 1–4 by siRNAs Bound to Non-Toxic Liposomes
by: Carlos Andrés Rodriguez-Salazar, et al.
Published: (2022-02-01) -
Liposome Photosensitizer Formulations for Effective Cancer Photodynamic Therapy
by: Sherif Ashraf Fahmy, et al.
Published: (2021-08-01) -
Treatment of Ulcerative Colitis by Cationic Liposome Delivered NLRP3 siRNA
by: Huang J, et al.
Published: (2023-08-01)